Atlantic Union Bankshares’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Buy
67,255
+41,982
+166% +$7.9M 0.21% 103
2026
Q1
$4.98M Sell
25,273
-23,796
-48% -$4.59M 0.1% 191
2025
Q4
$9.02M Buy
49,069
+405
+0.8% +$71K 0.17% 126
2025
Q3
$7.47M Buy
48,664
+336
+0.7% +$50.9K 0.14% 147
2025
Q2
$6.75M Buy
48,328
+46,228
+2,201% +$6.48M 0.15% 134
2025
Q1
$309K Sell
2,100
-190
-8% -$27.5K 0.02% 258
2024
Q4
$300K Sell
2,290
-18
-0.8% -$2.52K 0.02% 266
2024
Q3
$360K Hold
2,308
0.02% 259
2024
Q2
$360K Buy
+2,308
New +$347K 0.02% 261
2014
Q2
Sell
-167
Closed -$9K 129
2014
Q1
$9K Buy
+167
New +$10.8K ﹤0.01% 204

Other funds holding AZN

Atlantic Union Bankshares's AZN Position: Q2 2026 in Review

Atlantic Union Bankshares increased its AstraZeneca (AZN) stake by 166% in Q2 2026, buying an estimated $7.9M and bringing the position to 67,255 shares worth $12.8M. The position accounts for 0.21% of the portfolio, ranked #103.

Atlantic Union Bankshares first reported a position in AZN in Q1 2014 and has held it in 10 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Atlantic Union Bankshares held 67,255 shares of AstraZeneca worth $12.8M as of Q2 2026.
  • Atlantic Union Bankshares bought 41,982 AstraZeneca shares in Q2 2026, an estimated $7.9M.
  • AstraZeneca made up 0.21% of Atlantic Union Bankshares's portfolio in Q2 2026, its #103 holding.
  • Atlantic Union Bankshares first reported a position in AstraZeneca in Q1 2014 and has held it in 10 quarters since.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.